Skip to main content

Use of the CHA2DS2VASc score to reduce utilisation of transoesophageal echocardiography prior to ablation for atrial fibrillation

Abstract

Transoesophageal echocardiography (TOE) is frequently performed prior to atrial fibrillation (AF) ablation to exclude left atrial appendage (LAA) thrombus. However, patients undergoing AF ablation are usually anticoagulated, thus making the presence of thrombus unlikely in most cases. This study aimed to determine whether the CHA2DS2VASc scoring system can be used to identify patients that do not require TOE prior to AF ablation. In this single-centre retrospective study, local institutional and primary care databases and electronic patient records were searched to identify patients that had undergone TOE prior to AF ablation. Patient demographics, CHA2DS2VASc score, TOE findings and anticoagulation status were collected for analysis. Over a 7-year period (2008–2014), 332 patients (age 57 ± 10 years; 74% male) underwent TOE prior to proposed AF ablation. CHA2DS2VASc scores of 0, 1, 2 and >2 were found in 39, 34, 15 and 12% of patients, respectively. The prevalence of LAA thrombus was 0.6% (2 patients) and these 2 patients had risk scores of 2 and 4. No patients with a score of 0 or 1 had LAA thrombus. Patients that are classed as low risk by the CHA2DS2VASc score do not require a pre-ablation TOE to screen for LAA thrombus provided they are adequately anticoagulated. This would lead to a significant reduction in health care expenditures by reducing unnecessary TOE requests and thereby improve patient experience.

References

  1. Camm AJ, Kirchhof P, Lip GYH, Schotten U, Savelieva I, Ernst S, Van Gelder IC, Al-Attar N, Hindricks G, Prendergast B, et al. 2010 Guidelines for the management of atrial fibrillation. Europace 12 1360–1420. (doi:10.1093/europace/euq350)

    Article  Google Scholar 

  2. NICE 2014 NICE guidelines (CG180) Atrial fibrillation: the management of atrial fibrillation. London, UK: NICE. (available at: https://www.nice.org.uk/guidance/cg180)

    Google Scholar 

  3. Lip GYH, Nieuwlaat R, Pisters R, Lane DA, Crijns HJGM 2010 Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: The Euro Heart Survey on Atrial Fibrillation. Chest 137 263–272. (doi:10.1378/chest.09-1584)

    Article  Google Scholar 

  4. Oral H, Chugh A, Özaydin M, Hansen PR, Tolstrup JS, Lindhardsen J, Reich S, Igic P, Elmouchi D, Tschopp D, et al. 2006 Risk of thromboembolic events after percutaneous left atrial radiofrequency ablation of atrial fibrillation. Circulation 114 759–765. (doi:10.1161/CIRCULATIONAHA.106.641225)

    Article  Google Scholar 

  5. Bertaglia E, Zoppo F, Tondo C, Colella A, Mantovan R, Senatore G, Bottoni N, Carreras G, Corò L, Turco P, et al. 2007 Early complications of pulmonary vein catheter ablation for atrial fibrillation: a multicenter prospective registry on procedural safety. Heart Rhythm 4 1265–1271. (doi:10.1016/j.hrthm.2007.06.016)

    Article  Google Scholar 

  6. Bhargava M, Marrouche NF, Martin DO, Schweikert RA, Saliba W, Saad EB, Bash D, Williams-Andrews M, Rossillo A, Erciyes D, et al. 2004 Impact of age on the outcome of pulmonary vein isolation for atrial fibrillation using circular mapping technique and cooled-tip ablation catheter: a retrospective analysis. Journal of Cardiovascular Electrophysiology 15 8–13. (doi:10.1046/j.1540-8167.2004.03266.x)

    Article  Google Scholar 

  7. Calkins H, Brugada J, Packer DL, Cappato R, Chen SA, Crijns HJG, Damiano RJ Jr, Davies DW, Haines DE, Haissaguerre M, et al. 2007 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Europace 9 335–379. (doi:10.1093/europace/eum120)

    Article  Google Scholar 

  8. Romero J, Cao JJ, Garcia MJ, Taub CC 2014 Cardiac imaging for assessment of left atrial appendage stasis and thrombosis. Nature Reviews Cardiology 11 470–480. (doi:10.1038/nrcardio.2014.77)

    Article  Google Scholar 

  9. Puwanant S, Varr BC, Shrestha K, Hussain SK, Tang WHW, Gabriel RS, Wazni OM, Bhargava M, Saliba WI, Thomas JD, et al. 2009 Role of the CHADS2 score in the evaluation of thromboembolic risk in patients with atrial fibrillation undergoing transesophageal echocardiography before pulmonary vein isolation. Journal of the American College of Cardiology 54 2032–2039. (doi:10.1016/j.jacc.2009.07.037)

    Article  Google Scholar 

  10. Flachskampf FA, Wouters PF, Edvardsen T, Evangelista A, Habib G, Hoffman P, Hoffmann R, Lancellotti P, Pepi M 2014 Recommendations for transoesophageal echocardiography: EACVI update 2014. European Heart Journal: Cardiovascular Imaging 15 353–365. (doi:10.1093/ehjci/jeu015)

    PubMed  Google Scholar 

  11. Wazni OM, Tsao HM, Chen SA, Barrett C, Hao S, Patel D, Di Biase L, Martin DO, Kanj M, Arruda M, et al. 2006 Cardiovascular imaging in the management of atrial fibrillation. Journal of the American College of Cardiology 48 2077–2084. (doi:10.1016/j.jacc.2006.06.072)

    Article  Google Scholar 

  12. Stoddard MF, Singh P, Dawn B, Longaker RA 2003 Left atrial thrombus predicts transient ischemic attack in patients with atrial fibrillation. American Heart Journal 145 676–682. (doi:10.1067/mhj.2003.91)

    Article  Google Scholar 

  13. Zoppo F, Brandolino G, Berton A, Frigato N, Michieletto M, Zanocco A, Zerbo F, Bacchiega E, Lupo A, Bertaglia E 2012 Predictors of left atrium appendage clot detection despite on-target warfarin prevention for atrial fibrillation. Journal of Interventional Cardiac Electrophysiology 35 151–158. (doi:10.1007/s10840-012-9707-0)

    Article  CAS  Google Scholar 

  14. Herring N, Page S, Ahmed M, Burg MB, Hunter RJ, Earley J, Sporton SC, Newton JD, Sabharwal NK, Myerson SG, et al. 2013 The prevalence of low left atrial appendage emptying velocity and thrombus in patients undergoing catheter ablation for atrial fibrillation on uninterrupted peri-procedural Warfarin therapy. Journal of Atrial Fibrillation 5 28–35. (doi:10.4022/jafib.761)

    Google Scholar 

  15. Yarmohammadi H, Varr BC, Puwanant S, Lieber E, Williams SJ, Klostermann T, Jasper SE, Whitman C, Klein AL 2012 Role of CHADS 2 score in evaluation of thromboembolic risk and mortality in patients with atrial fibrillation undergoing direct current cardioversion (from the ACUTE Trial Substudy). American Journal of Cardiology 110 222–226. (doi:10.1016/j.amjcard.2012.03.017)

    Article  Google Scholar 

  16. Yarmohammadi H, Klosterman T, Grewal G, Alraies MC, Varr BC, Lindsay B, Zurick I, Shrestha K, Tang WHW, Bhargava M, et al. 2013 Efficacy of the CHADS2 scoring system to assess left atrial thrombogenic milieu risk before cardioversion of non-valvular atrial fibrillation. American Journal of Cardiology 112 678–683. (doi:10.1016/j.amjcard.2013.04.047)

    Article  Google Scholar 

  17. Di Biase L, Lakkireddy D, Trivedi C, Deneke T, Martinek M, Mohanty S, Mohanty P, Prakash S, Bai R, Reddy M, et al. 2015 Feasibility and safety of uninterrupted periprocedural apixaban administration in patients undergoing radiofrequency catheter ablation for atrial fibrillation: Results from a multicenter study. Heart Rhythm 12 1162–1168. (doi:10.1016/j.hrthm.2015.02.028)

    Article  Google Scholar 

  18. Nairooz R, Sardar P, Pino M, Aronow WS, Sewani A, Mukherjee D, Paydak H, Maskoun W 2015 Meta-analysis of risk of stroke and thrombo-embolism with rivaroxaban versus vitamin K antagonists in ablation and cardioversion of atrial fibrillation. International Journal of Cardiology 187 345–353. (doi:10.1016/j.ijcard.2015.03.323)

    Article  Google Scholar 

  19. Rillig A, Lin T, Plesman J, Heeger CH, Lemes C, Metzner A, Mathew S, Wissner E, Wohlmuth P, Ouyang F, et al. 2016 Apixaban, rivaroxaban, and dabigatran in patients undergoing atrial fibrillation ablation. Journal of Cardiovascular Electrophysiology 27 147–153. (doi:10.1111/jce.12856)

    Article  Google Scholar 

  20. Sticherling C, Marin F, Birnie D, Boriani G, Calkins H, Dan GA, Gulizia M, Halvorsen S, Hindricks G, Kuck K, et al. 2015 Antithrombotic management in patients undergoing electrophysiological procedures: a European Heart Rhythm Association (EHRA) position document endorsed by the ESC Working Group Thrombosis, Heart Rhythm Society (HRS), and Asia Pacific Heart Rhythm Society (APHRS). Europace 17 1197–1214. (doi:10.1093/europace/euv190)

    Article  Google Scholar 

  21. Kawabata M, Goya M, Sasaki T, Maeda S, Shirai Y, Nishimura T, Yoshitake T, Shiohira S, Isobe M, Hirao K 2017 Left atrial appendage thrombi formation in Japanese non-valvular atrial fibrillation patients during anticoagulation therapy–warfarin vs direct oral anticoagulants. Circulation Journal 81 645–651. (doi:10.1253/circj.CJ-16-1089)

    Article  CAS  Google Scholar 

  22. Wyrembak J, Campbell KB, Steinberg BA, Bahnson TD, Daubert JP, Velazquez EJ, Samad Z, Atwater BD 2017 Incidence and predictors of left atrial appendage thrombus in patients treated with nonvitamin K oral anticoagulants versus warfarin before catheter ablation for atrial fibrillation. American Journal of Cardiology 119 1017–1022. (doi:10.1016/j.amjcard.2016.12.008)

    Article  CAS  Google Scholar 

  23. Scherr D, Dalal D, Chilukuri K, Dong J, Spragg D, Henrikson CA, Nazarian S, Cheng A, Berger RD, Abraham TP, et al. 2009 Incidence and predictors of left atrial thrombus prior to catheter ablation of atrial fibrillation. Journal of Cardiovascular Electrophysiology 20 379–384. (doi:10.1111/j.1540-8167.2008.01336.x)

    Article  Google Scholar 

  24. McCready JW, Nunn L, Lambiase PD, Ahsan SY, Segal OR, Rowland E, Lowe MD, Chow AW 2010 Incidence of left atrial thrombus prior to atrial fibrillation ablation: Is pre-procedural transoesophageal echocardiography mandatory? Europace 12 927–932. (doi:10.1093/europace/euq074)

    Article  Google Scholar 

  25. Calvo N, Mont L, Vidal B, Montserrat S, Andreu D, Tamborero D, Pare C, Azqueta M, Berruezo A, Brugada J, et al. 2011 Usefulness of transoesophageal echocardiography before circumferential pulmonary vein ablation in patients with atrial fibrillation: is it really mandatory? Europace13 486–491. (doi:10.1093/europace/euq456)

    Article  CAS  Google Scholar 

  26. Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA, Crijns HJG, Damiano RJ Jr, Davies DW, DiMarco J, et al. 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Europace 14 528–606. (doi:10.1093/europace/eus027)

    Article  Google Scholar 

  27. Floria M, Roy LD, Xhaet O, Blommaert D, Jamart J, Gerard M, Dormal F, Deceuninck O, Ambarus V, Marchandise B, et al. 2013 Predictive value of thromboembolic risk scores before an atrial fibrillation ablation procedure. Journal of Cardiovascular Electrophysiology 24 139–145. (doi:10.1111/j.1540-8167.2012.02442.x)

    Article  Google Scholar 

  28. Willens HJ, Gómez-Marín O, Nelson K, Denicco A, Moscucci M 2013 Correlation of CHADS2 and CHA2DS2-VASc scores with transesophageal echocardiography risk factors for thromboembolism in a multiethnic united states population with nonvalvular atrial fibrillation. Journal of the American Society of Echocardiography 26 175–184. (doi:10.1016/j.echo.2012.11.002)

    Article  Google Scholar 

  29. Nishikii-Tachibana M, Murakoshi N, Seo Y, Xu DZ, Yamamoto M, Ishizu T, Atsumi A, Machino-Ohtsuka T, Kuroki K, Yamasaki H, et al. 2015 Prevalence and clinical determinants of left atrial appendage thrombus in patients with atrial fibrillation before pulmonary vein isolation. American Journal of Cardiology 116 1368–1373. (doi:10.1016/j.amjcard.2015.07.055)

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Benoy N. Shah MD MRCP FESC.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://doi.org/creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Atkinson, C., Hinton, J., Gaisie, E.B. et al. Use of the CHA2DS2VASc score to reduce utilisation of transoesophageal echocardiography prior to ablation for atrial fibrillation. Echo Res Pract 4, 45–52 (2017). https://doi.org/10.1530/ERP-17-0042

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1530/ERP-17-0042

Key Words